Reported 0 shares, down 95,262 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
32 managers reported INNOVATE BIOPHARMACEUTICLS for Q3 2019.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| SABBY MANAGEMENT LLC | Reduced | 1,248,814 | -87,434 | 0.72% | $1,336,000 | 2 qtrs |
| VANGUARD GROUP INC | Reduced | 730,130 | -225,014 | < 0.01% | $781,000 | 6 qtrs |
| BlackRock Inc | Reduced | 341,807 | -4,983 | < 0.01% | $365,000 | 7 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 113,968 | -2,662 | < 0.01% | $121,000 | 6 qtrs |
| MORGAN STANLEY | Reduced | 63,807 | -8,755 | < 0.01% | $68,000 | 7 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 27,519 | -165,945 | < 0.01% | $29,000 | 6 qtrs |
| BREWIN DOLPHIN Ltd | Unchanged | 25,000 | 0 | < 0.01% | $26,750 | 2 qtrs |
| Summit X LLC | New | 19,000 | +19,000 | < 0.01% | $19,000 | 1 qtr |
| Virtu Financial LLC | Reduced | 17,075 | -45,747 | < 0.01% | $18,000 | 2 qtrs |
| THE BANK OF NEW YORK MELLON CORPORATION | Unchanged | 14,692 | 0 | < 0.01% | $16,000 | 6 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2019
- Filed
- November 14, 2019
- Filing type
- 13F-HR
- Position type
- COM PAR
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.